Vis beschermt tegen hartziektes en
aderverkalking.*
1 From the Division of Endocrinology, Diabetes and
Clinical Nutrition, Oregon Health & Science University, Portland, OR
2 Reprints not available. Address correspondence to WE
Connor, Division of Endocrinology, Diabetes and Clinical Nutrition,
L465, Oregon Health & Science University, 3181 SW Sam Jackson Park
Road, Portland, OR 97239. E-mail: connorw@ohsu.edu.
The pioneering observations in
Greenland Eskimos suggest that high intakes of n–3 fatty acids from
fish and sea mammals prevent cardiovascular disease. This is in
contrast with the high frequency of cardiovascular disease in Western
populations, who have low fish intakes and high intakes of
cholesterol and saturated fat. This presumed benefit of n–3 fatty
acid intake from fish stimulated a large volume of scientific
research (1). The evidence has suggested that dietary n–3 fatty
acids might ameliorate the atherosclerotic process itself, which is
the cause of coronary artery disease. Populations that consume more
n–3 fatty acids from fish have a lower incidence of coronary artery
disease. Patients with coronary artery disease who eat fish appear to
have a lower subsequent rate of coronary artery disease and lower
total mortality, especially from sudden death. The decrease in deaths
from coronary artery disease as a result of fish-oil n–3 fatty acid
intakes results from their antiarrhythmic effects (less sudden death
from ventricular fibrillation and ventricular tachycardia), but
myocardial infarction still occurred from thrombotic atherosclerosis.
These studies included clinical trials in male survivors of
myocardial infarction as well as epidemiologic associations in both
men and women. Fish-oil feeding experiments in humans have shown many
potential antiatherogenic effects (2, 3): a lowering of plasma lipid
and lipoprotein concentrations and decreased platelet aggregation,
an antithrombotic action (4, 5). Other factors believed to be involved
in the pathogenesis of atherosclerosis are also affected by n–3
fatty acids (3), including the inhibition of intimal hyperplasia in
canine autologous vein grafts, a decreased endothelial cell
production of a platelet-derived growth factor- like protein, an
increased activity of endothelium-derived nitric oxide (vasodilating), and
a reduction in the cytokines involved in the inflammatory response
associated with atherosclerosis.
Furthermore, fish oil has
prevented the development of experimental atherosclerosis in pigs and
rhesus monkeys. In the pig study, the intima of the coronary arteries
was damaged by a balloon catheter at the same time that the animals
were fed cholesterol and fat, and severe coronary atherosclerosis
resulted (6). When the pigs were fed cod liver oil, which is rich in
n–3 fatty acids, cholesterol, and saturated fat, a lower incidence
of atherosclerosis developed despite little effect on the lowering of
plasma cholesterol. This result suggests that fish oil had an effect
on atherosclerosis that was unrelated to plasma lipid concentrations.
In another study, the ingestion of fish oil led to less carotid
atherosclerosis in monkeys fed a diet high in cholesterol and fat;
the monkeys experienced some reduction in total cholesterol and LDL
cholesterol (7). The data to date in humans have been inconclusive in
showing that fish oil prevents restenosis after coronary artery
balloon angioplasty.
In this issue of the Journal,
the association between high fish and n–3 fatty acid intakes and a
reduction in the incidence of atherosclerosis was given further
credence (8). Fish intake was associated with a reduced progression
of coronary atherosclerosis in postmenopausal women with coronary
artery disease. In particular, the consumption of
2 servings or more of fish or 1 serving or more of tuna
or dark fish each week was associated with smaller increases in the
percentage of stenosis of the coronary arteries as documented by
angiography. This association was particularly evident in diabetic
women after adjustments for age, cardiovascular disease risk factors,
and the dietary intakes of fatty acids, cholesterol, fiber, and
alcohol. This association was not significant in nondiabetic women.
Fish consumption was also associated with a smaller decrease in
minimum coronary artery diameter and with fewer new lesions. These
data are buttressed by the observation that the fish-oil fatty acids
eicosapentaenoic and docosahexaenoic acids are actually incorporated
into the phospholipids and cholesterol esters of severe
atherosclerotic lesions in humans (3). Thus, it makes sense that a
high consumption of fish oil will prevent the progression of
atherosclerosis.
A particularly important
finding of this study was that the benefit of a high fish-oil intake
was especially apparent in diabetic women. Diabetes has now been
ranked as a major risk factor for subsequent heart disease, in the
same category as a previous episode of coronary artery disease. The
incidence of diabetes has greatly increased as a result of the
epidemic of obesity. The results of this study agree well with the
epidemiologic observation that the risk of coronary heart disease is
much lower in diabetic women who consume fish (9).
Despite the favorable effect
of fish intake on coronary atherosclerosis in postmenopausal women
with overt coronary artery disease, one must be cautious in
interpreting these data. Fish intake did not prevent atherosclerosis
but rather reduced its progression. In other words, atherosclerotic
progression occurred more slowly with fish consumption. Clearly, this
multifactorial disease—atherosclerosis—is not going to be cured
or even prevented by fish intake alone. The predominant risk factors
for coronary artery disease—smoking, hypertension, hyperlipidemia
(particularly elevated LDL-cholesterol concentrations), obesity,
diabetes, and low physical activity—must still be dealt with to
obtain the best possible outcome. As far as diet is concerned,
intakes of the predominant progenitors of atherosclerotic
plaque—dietary cholesterol and saturated fat—must be reduced.
What needs to be added to the usual low-fat diet prescription of
fruit, vegetables, grains, beans, and small amount of animal products
is fish.
Dietary factors that
contribute to the development and progression of atherosclerosis,
namely dietary cholesterol and fat (particularly saturated fat), have
been known for almost 100 y. Monkeys fed egg yolk developed high
cholesterol concentrations and severe coronary atherosclerosis (10).
The removal of cholesterol from the monkeys’ diets led to normal
cholesterol concentrations and a considerable reduction in the amount
of atherosclerotic plaque, from 60% blockage to 20% occlusion.
The influence of dietary factors on chronic disease is always of great interest, especially because these factors apply to atherosclerotic coronary artery disease. Dietary changes made to prevent disease have special value in that the cost of these changes is minimal compared with that associated with clinical interventions, and these changes can be applied to the whole population as a public health measure. The encouragement of fish consumption as a measure to prevent the ravages of coronary artery disease is an important public health message. (sept. 2004)